BACTERIAL ENDOCARDITIS IN PATIENTS WITH ALCAPTONURIC OCHRONOSIS

Lj. Smiljić ,
Lj. Smiljić

Internal clinic, Medical faculty Pristina , Kosovska Mitrovica , Kosovo*

S. Ristić ,
S. Ristić

Medical faculty Foca, Republika Srpska Bosnia and Herzegovina

M. Antić
M. Antić

Medical faculty Foca, Republika Srpska Bosnia and Herzegovina

Published: 01.01.2009.

Volume 37, Issue 1 (2009)

pp. 125-128;

https://doi.org/10.70949/pramed200901286S

Abstract

Alkaptonuria is one of 4 disorders originally defined as an inborn error of metabolism. The hallmark of the disease is passage of urine that becomes black when left standing. There is a familial pattern of inheritance. The defect lies in the catabolic pathway of tyrosine. The product, homogentisic acid, in deficiency of the hepatic enzyme homogentisate 1,2- dioxygenase (HGO) accumulates in the blood, but is rapidly cleared in the kidney and excreted. Upon contact with air, homogentisic acid is oxidized to form a pigmentlike polymeric material responsible for the black color of standing urine. Although homogentisic acid blood levels are kept very low through rapid kidney clearance, over time homogentisic acid is deposited in cartilage throughout the body and is converted to the pigmentlike polymer through an enzyme-mediated reaction that occurs chiefly in collagenous tissues. As the polymer accumulates within cartilage, a process that takes many years, the normally transparent tissues become slate blue, an effect ordinarily not seen until adulthood. The earliest sign of the disorder is the tendency for diapers to stain black.. but in most cases desease is hardly diagnosed before the fourth decade of life, external signs of pigment deposition, called ochronosis, begin to appear. The slate blue, gray, or black discoloration of sclerae and ear cartilage is indicative of widespread staining of the body tissues, particularly cartilage. The hips, knees, and intervertebral joints are affected most commonly and show clinical symptoms resembling rheumatoid arthritis. Because of calcifications that occur in these sites, however, the radiologic picture is more consistent with osteoarthritis.

Keywords

References

1.
Kihara T, Yasuda M, Watanabe H, Suenaga Y, Shiokawa S, Wada T, et al. Coexistence of ochronosis and rheumatoid arthritis. Clin Rheumatol. 13:135–8.
2.
Forslind K, Wollheim FA, Akesson B, Rydholm U. Alkaptonuria and ochronosis in three siblings. Ascorbic acid treatment monitored by urinary HGA excretion. Clin Exp Rheumatol. 6:289–92.
3.
Morava E, Kosztolanyi G, Engelke UF, Wevers RA. Reversal of clinical symptoms and radiographic abnormalities with protein restriction and ascorbic acid in alkaptonuria. Ann Clin Biochem. 40:108–11.
4.
Cercek M, Prokselj K, Kozelj M. Aortic valve stenosis in alkaptonuric ochronosis. J Heart Valve Dis. 11:386–8.
5.
Kragel AH, Lapa JA, Roberts WC. Cardiovascular findings in alkaptonuric ochronosis. Am Heart J. 120(6 Pt 1):1460–3.
6.
JJ G, GM P. Cardiovascular ochronosis. Arch Pathol Lab Med. 111:991–4.
7.
Vlay SC, Hartman AR, Culliford AT. Alkaptonuria and aortic stenosis. Ann Intern Med. 104(446).
8.
Cortina R, Moris C, Astudillo A, Gosalbez F, Cortina A. Familial ochronosis. Eur Heart J. 16:285–6.
9.
O’Brien WM, Du BN, Bunim JJ. Biochemical, pathologic and clinical aspects of alcaptonuria, ochronosis and ochotronotic arthropathy. Review of world literature (1584-1962. Am J Med. 34:813–38.
10.
Roth A, Schmidt K, Muller KM, Haaker R. A case report: Ochronosis in combination with chondrocalcinosis. Z Orthop Ihre Grenzgeb. 137:76–8.
11.
Weinberger KA. The coexistence of ochronosis and ankylosing spondylitis. J Rheumatol. 18:1948–9.
12.
Yagan R, Khan MA. The coexistence of ochronosis and ankylosing spondylitis. J Rheumatol. 18:1639–40.
13.
Gemignani G, Olivieri I, Semeria R, Giustarini S, Pasero G. Coexistence of ochronosis and ankylosing spondylitis. J Rheumatol. 17:1707–9.
14.
Simianer S, Krause D, Rau R. Concomitant manifestation of ochronosis and chronic polyarthritis in a patient. Z Rheumatol. 57:50–2.
15.
Kottinen YT, Hoikka V, Landtman M, Saari H, Santavirta S, Metsarinne K, et al. Ochronosis: A report of a case and a review of literature. Clin Exp Rheumatol. 7:435–44.
16.
Kabasakal Y, Kiyici I, Ozmen D, Yagci A, Gumusdis G. Spinal abnormalities similar to ankylosing spondylitis in a 58-year-old woman with ochronosis. Clin Rheumatol. 14:355–7.
17.
Borman P, Bodur H, Ciliz D. Ochronotic arthropathy. Rheumatol Int. 21:205–9.
18.
Hamdi N, Cooke TD, Hassan B. Ochronotic arthropathy: Case report and review of the literature. Int Orthop. 23:122–5.
19.
Rodriguez JM, Timm DE, Titus GP, Bernabe D, Criado O, Mueller HA, et al. Structural and functional analysis of mutations in alkaptonuria. Hum Mol Genet. 9:2341–50.
20.
Pollak MR, Chou YH, Cerda JJ, Steinmann B, Du BN, Seidman JG, et al. Homozygosity mapping of the gene for alkaptonuria to chromosome 3q2. Nat Genet. 5:201–4.
21.
BN, JE S, L L, V Z. Alcaptonuria and ochronotic arthritis. Bull Rheum Dis. 8:163–4.
22.
Garrod E. The incidence of alkaptonuria: A study in chemical individuality. Lancet. 2:1616–20.
23.
JJ G. The pathology of alkaptonuric ochronosis. Hum Pathol. 20:40–6.
24.
Lee SL, Stenn FF. Characterization of mummy bone ochronotic pigment. JAMA. 240:136–8.
25.
Zatkova A, Chmelikova A, Polakova H, Ferakova E, Kadasi L. Rapid detection methods for five HGO gene mutations causing alkaptonuria. Clin Genet. 63:145–9.
26.
Phornphutkul C, Introne WJ, Perry MB, Bernardini I, Murphey MD, Fitzpatrick DL, et al. Natural history of alkaptonuria. N Engl J Med. 347:2111–21.
27.
Janocha S, Wolz W, Srsen S, Srsnova K, Montagutelli X, Guenet JL, et al. The human gene for alkaptonuria (AKU) maps to chromosome 3q. Genomics. 19:5–8.

Citation

Copyright

Article metrics

Google scholar: See link

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Most read articles

Indexed by